

Fundamental dimension Equity attribute | BWFGLeader $67.20▲+0.25% Cap $535.7MP/E 12.4x QuantScore67/100 | BOTJPeer $29.73▲+2.93% Cap $135.1MP/E 11.8x QuantScore60/100 | CBFVPeer $38.65▲+0.89% Cap $196.4MP/E 27.0x QuantScore53/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
94/100 |
71/100 |
94/100 |
Valuation Multiples, PEG & DCF upside | 98/100 | 88/100 | 62/100 |
Health Piotroski, Altman Z, leverage & liquidity | 37/100 | 30/100 | 32/100 |
Growth Revenue / earnings growth & margins | 52/100 | 51/100 | 23/100 |
Sentiment Analyst ratings, targets & revisions | 56/100 | — | 53/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 12.4x | 11.8x | 27.0x |
Forward P/E (next FY) | 11.6x | — | 12.2x |
EV / EBITDA (TTM) | 7.1x | 9.9x | 23.7x |
Price / Sales | 2.5x | 2.2x | 2.7x |
Price / Free Cash Flow | 15.5x | 10.6x | 10.1x |
PEG ratio | 0.12 | 0.20 | -0.72 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 5 / 9 | 6 / 9 |
Altman Z-Score | 0.35 (Distress) | -0.80 (Distress) | 0.23 (Distress) |
Total debt / equity | 0.31 | 0.10 | 0.62 |
Quick ratio | 1.0x | 0.0x | 1.2x |
Interest coverage | 0.6x | 0.8x | 0.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +6.1% | +6.0% | -13.3% |
Net income growth YoY | +260.3% | +13.6% | -61.1% |
Gross margin (TTM) | 55.8% | 77.3% | 65.1% |
Operating margin (FY) | 23.3% | 17.8% | 7.7% |
FCF margin (FY) | 13.1% | 16.8% | 25.0% |
5. Trailing price performancePrice change over period |
1M return | +1.1% | +11.1% | +4.1% |
3M return | +8.0% | +10.4% | +7.7% |
6M return | +32.9% | +27.7% | +9.8% |
Year to date | +46.7% | +60.0% | +10.9% |
1Y return | +51.8% | +83.0% | +15.0% |
3Y return | +186.0% | +201.8% | +83.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $383.15 +470.2% upside | $27.58 -7.2% premium | $31.25 -19.1% premium |
Wall Street consensus target | — — | — — | $44.00 +13.8% · range $44.00–$44.00 |
Consensus stance | 67% Buy33% Hold0% Sell | — | 67% Buy33% Hold0% Sell |